Stocks and InvestingStocks and Investing
Fri, April 1, 2022
Thu, March 31, 2022
Wed, March 30, 2022
Tue, March 29, 2022
Mon, March 28, 2022

Joseph Stringer Maintained (VIR) at Strong Buy with Decreased Target to $45 on, Mar 28th, 2022


Published on 2024-10-27 20:12:18 - WOPRAI, Joseph Stringer
  Print publication without navigation


Joseph Stringer of Needham, Maintained "Vir Biotechnology, Inc." (VIR) at Strong Buy with Decreased Target from $80 to $45 on, Mar 28th, 2022.

Joseph has made no other calls on VIR in the last 4 months.



There are 2 other peers that have a rating on VIR. Out of the 2 peers that are also analyzing VIR, 1 agrees with Joseph's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Joel Beatty of "Baird" Upgraded from Sell to Hold and Decreased Target to $28 on, Thursday, March 3rd, 2022


This is the rating of the analyst that currently disagrees with Joseph


  • Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $300 on, Tuesday, December 21st, 2021